Northeast Pharmaceutical Group Co Ltd (000597) — Financial Flexibility Index
Northeast Pharmaceutical Group Co Ltd (000597) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥285.57 Million (operating CF CN¥274.09 Million minus capex CN¥11.48 Million) represents 0% of total liabilities (CN¥8.05 Billion). Check 000597 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Northeast Pharmaceutical Group Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Northeast Pharmaceutical Group Co Ltd across 28 annual periods. See Northeast Pharmaceutical Group Co Ltd (000597) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Northeast Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Northeast Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see 000597 company net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | CN¥1.20 Billion | CN¥1.11 Billion | CN¥7.22 Billion | ▲ +61.2% |
| 2024 | 0.10x | CN¥918.19 Million | CN¥758.76 Million | CN¥8.88 Billion | ▲ +27.3% |
| 2023 | 0.08x | CN¥822.18 Million | CN¥586.75 Million | CN¥10.11 Billion | ▼ -45.3% |
| 2022 | 0.15x | CN¥1.35 Billion | CN¥1.11 Billion | CN¥9.10 Billion | ▲ +52.6% |
| 2021 | 0.10x | CN¥866.31 Million | CN¥746.51 Million | CN¥8.89 Billion | ▼ -19.3% |
| 2020 | 0.12x | CN¥971.30 Million | CN¥570.92 Million | CN¥8.04 Billion | ▲ +79.0% |
| 2019 | 0.07x | CN¥581.77 Million | CN¥352.60 Million | CN¥8.62 Billion | ▼ -35.6% |
| 2018 | 0.10x | CN¥850.83 Million | CN¥285.09 Million | CN¥8.13 Billion | ▲ +642.6% |
| 2017 | 0.01x | CN¥113.43 Million | CN¥-301.20 Million | CN¥8.05 Billion | ▼ -81.5% |
| 2016 | 0.08x | CN¥561.52 Million | CN¥384.51 Million | CN¥7.36 Billion | ▲ +7.7% |
| 2015 | 0.07x | CN¥445.74 Million | CN¥99.70 Million | CN¥6.29 Billion | ▼ -28.9% |
| 2014 | 0.10x | CN¥579.26 Million | CN¥46.99 Million | CN¥5.81 Billion | ▲ +219.8% |
| 2013 | 0.03x | CN¥185.64 Million | CN¥-266.38 Million | CN¥5.96 Billion | ▼ -50.1% |
| 2012 | 0.06x | CN¥264.99 Million | CN¥86.09 Million | CN¥4.24 Billion | ▲ +36.9% |
| 2011 | 0.05x | CN¥188.33 Million | CN¥-233.32 Million | CN¥4.13 Billion | ▼ -77.9% |
| 2010 | 0.21x | CN¥729.89 Million | CN¥255.96 Million | CN¥3.54 Billion | ▼ -43.9% |
| 2009 | 0.37x | CN¥1.48 Billion | CN¥615.91 Million | CN¥4.03 Billion | ▼ -13.0% |
| 2008 | 0.42x | CN¥1.07 Billion | CN¥709.03 Million | CN¥2.53 Billion | ▲ +218.9% |
| 2007 | 0.13x | CN¥286.34 Million | CN¥198.56 Million | CN¥2.16 Billion | ▲ +391.5% |
| 2006 | -0.05x | CN¥-58.16 Million | CN¥-106.00 Million | CN¥1.28 Billion | ▼ -129.5% |
| 2005 | 0.15x | CN¥215.06 Million | CN¥111.40 Million | CN¥1.40 Billion | ▼ -12.4% |
| 2004 | 0.18x | CN¥272.20 Million | CN¥211.06 Million | CN¥1.55 Billion | ▼ -8.7% |
| 2003 | 0.19x | CN¥317.54 Million | CN¥230.08 Million | CN¥1.65 Billion | ▲ +77.8% |
| 2002 | 0.11x | CN¥195.48 Million | CN¥157.41 Million | CN¥1.81 Billion | ▲ +61.5% |
| 2001 | 0.07x | CN¥125.42 Million | CN¥78.84 Million | CN¥1.87 Billion | ▲ +144.5% |
| 2000 | 0.03x | CN¥48.31 Million | CN¥36.13 Million | CN¥1.76 Billion | ▼ -25.9% |
| 1999 | 0.04x | CN¥64.03 Million | CN¥54.62 Million | CN¥1.73 Billion | ▲ +324.9% |
| 1998 | 0.01x | CN¥13.84 Million | CN¥-7.59 Million | CN¥1.59 Billion | — |